ABOUT LENMELDY

The FDA assessed the safety and effectiveness of atidarsagene autotemcel based on details from 37 children who been given atidarsagene autotemcel in two single-arm, open up-label medical trials and in an expanded entry system.[seven] Young children who acquired therapy with atidarsagene autotemcel were being as compared to untreated young children